Evidence map›Paper›PMID 38005373›Full record

ArticleMolecules (Basel, Switzerland)2023

New Meroterpenoid Derivatives from the Pomegranate-Derived Endophytic Fungus

Alaa Anwar, Mohamed S Elnaggar, Ahmed M Elissawy, Nehal Ibrahim, Attila Mándi, Tibor Kurtán, Zhen Liu, Sherweit H El-Ahmady, Rainer Kalscheuer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alaa AnwarDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Abbassia, Cairo 11566, Egypt.ORCID 0000-0002-5309-8529
Mohamed S ElnaggarDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Abbassia, Cairo 11566, Egypt.ORCID 0000-0003-1967-6046
Ahmed M ElissawyDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Abbassia, Cairo 11566, Egypt.ORCID 0000-0003-1584-7653
Nehal IbrahimDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Abbassia, Cairo 11566, Egypt.ORCID 0000-0002-6526-298X
Attila MándiDepartment of Organic Chemistry, University of Debrecen, P.O. Box 400, 4002 Debrecen, Hungary.ORCID 0000-0002-7867-7084
Tibor KurtánDepartment of Organic Chemistry, University of Debrecen, P.O. Box 400, 4002 Debrecen, Hungary.ORCID 0000-0002-8831-8499
Zhen LiuKey Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Medicine, Hunan Normal University, Changsha 410013, China.ORCID 0000-0003-3314-7853
Sherweit H El-AhmadyDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Abbassia, Cairo 11566, Egypt.
Rainer KalscheuerInstitute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University, Universitätsstrasse 1, 40225 Düsseldorf, Germany.ORCID 0000-0002-3378-2067

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we report the isolation of two new meroterpenoids, miniolutelide D (

Indexed as

Methicillin-Resistant Staphylococcus aureusPomegranateTalaromycesFruitMolecular StructureStaphylococcus aureusabsolute configurationantimicrobial activityendophytesmeroterpenoidsstructural elucidationTalaromyces purpureogenus

Identifiers

PMID38005373
PMCPMC10673506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.